4.5 Article

ATP-Sensitive Potassium Channel-Deficient Mice Show Hyperphagia but Are Resistant to Obesity

期刊

DIABETES & METABOLISM JOURNAL
卷 35, 期 3, 页码 219-225

出版社

KOREAN DIABETES ASSOC
DOI: 10.4093/dmj.2011.35.3.219

关键词

Appetite; Hypothalamus; Intra-abdominal fat; K-ATP channels

资金

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0069055]
  2. National Research Foundation of Korea [2009-0069055] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Background: The hypothalamus, the center for body weight regulation, can sense changes in blood glucose level based on ATP-sensitive potassium (K-ATP) channels in the hypothalamic neurons. We hypothesized that a lack of glucose sensing in the hypothalamus affects the regulations of appetite and body weight. Methods: To evaluate this hypothesis, the responses to glucose loading and high fat feeding for eight weeks were compared in Kir6.2 knock-out (KO) mice and control C57BL/6 mice, because Kir6.2 is a key component of the K-ATP channel. Results: The hypothalamic neuropeptide Y (NPY) analyzed one hour after glucose injection was suppressed in C57BL/6 mice, but not in Kir6.2 KO mice, suggesting a blunted hypothalamic response to glucose in Kir6.2 KO mice. The hypothalamic NPY expression at a fed state was elevated in Kir6.2 KO mice and was accompanied with hyperphagia. However, the retroperitoneal fat mass was markedly decreased in Kir6.2 KO mice compared to that in C57BL/6 mice. Moreover, the body weight and visceral fat following eight weeks of high fat feeding in Kir6.2 KO mice were not significantly different from those in control diet-fed Kir6.2 KO mice, while body weight and visceral fat mass were elevated due to high fat feeding in C57BL/6 mice. Conclusion: These results suggested that Kir6.2 KO mice showed a blunted hypothalamic response to glucose loading and elevated hypothalamic NPY expression accompanied with hyperphagia, while visceral fat mass was decreased, suggesting resistance to diet-induced obesity. Further study is needed to explain this phenomenon.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Peroxiredoxin 2 deficiency does not affect insulin resistance and oxidative stress in high-fat diet-fed obese mice

Jae-Ho Kim, Hye-Na Cha, Yong-Woon Kim, So-Young Park

Summary: The results of this study suggest that Prx2 does not affect high-fat diet-induced oxidative stress and insulin resistance in mice.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)

Article Endocrinology & Metabolism

Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study

Seung Min Chung, Min Kyu Kang, Jinho Jung, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee, Rohit Loomba, Jung Gil Park, Jun Sung Moon

Summary: The study investigated the long-term effect of changes in hepatic steatosis on the risk of developing T2DM, finding that patients with persistent steatosis had a higher risk of diabetes. The initial severity and aggravation of steatosis are independent predictors of future development of T2DM.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Article Hematology

Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes

Il Rae Park, Jimi Choi, Eun Young Ha, Seung Min Chung, Jun Sung Moon, Sehyun Shin, Sin Gon Kim, Kyu Chang Won

Summary: This study investigated the diagnostic potential of a hemorheological parameter, critical shear stress (CSS), for diabetic kidney disease (DKD), and found that CSS can be used as an additive diagnostic index for DKD. In combination with albumin-to-creatinine ratio (ACR) and glomerular filtration rate (GFR), CSS can identify DKD more accurately.

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2022)

Article Biochemistry & Molecular Biology

MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators

Eun Ju Lee, Sibhghatulla Shaikh, Mohammad Hassan Baig, So-Young Park, Jeong Ho Lim, Syed Sayeed Ahmad, Shahid Ali, Khurshid Ahmad, Inho Choi

Summary: This study reports the potential of novel peptides MIF1 and MIF2 derived from MSTN in enhancing myogenesis and reducing adipogenesis. Modified MIF1 and MIF2 showed better cell proliferation and differentiation compared to non-modified peptides. Pretreatment of mice with (Ac)-MIF1 or (Ac)-MIF2-(NH2) promoted muscle regeneration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Endocrinology & Metabolism

Diabetes Fact Sheet in Korea 2021

Jae Hyun Bae, Kyung-Do Han, Seung-Hyun Ko, Ye Seul Yang, Jong Han Choi, Kyung Mook Choi, Hyuk-Sang Kwon, Kyu Chang Won

Summary: This study investigated the prevalence and management of diabetes mellitus in Korea. The results showed high prevalence of diabetes among Korean adults, with only a small percentage of patients achieving glycemic, blood pressure, and lipid controls. The study also highlighted gender differences in self-management behaviors.

DIABETES & METABOLISM JOURNAL (2022)

Article Multidisciplinary Sciences

Characterization of adipose depot-specific stromal cell populations by single-cell mass cytometry

Ju Hee Lee, Kafi N. Ealey, Yash Patel, Navkiran Verma, Nikita Thakkar, So Young Park, Jae-Ryong Kim, Hoon-Ki Sung

Summary: The increased prevalence of obesity and metabolic diseases has led to the study of adipose tissue biology. Using CyTOF technology, this study characterized immune and stromal cells in different adipose tissue depots and identified distinct subtypes of adipose precursor cells with different responses to high-fat diet.

ISCIENCE (2022)

Article Medical Laboratory Technology

c-Abl tyrosine kinase inhibition attenuate oxidative stress-induced pancreatic b-Cell dysfunction via glutathione antioxidant system

Udayakumar Karunakaran, Suma Elumalai, Jun Sung Moon, Kyu Chang Won

Summary: Chronic oxidative stress plays a key role in beta-cell loss in diabetes, and recent studies have linked this loss to ferroptotic-like death. Oxidative stress leads to the loss of reduced/oxidized glutathione and degradation of glutathione peroxidase 4, promoting lipid peroxidation and ferroptotic-like cell damage. Inhibiting the c-Abl kinase and inducing ERRy preserves beta-cell function by increasing the GSH/GSSG ratio and inhibiting lipid peroxidation. This study provides evidence that ERRy-induced GLS1 expression augments the glutathione antioxidant system, improving beta-cell function and survival under oxidative stress conditions.

TRANSLATIONAL RESEARCH (2022)

Review Physiology

Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies

Mohammad Hassan Baig, Khurshid Ahmad, Jun Sung Moon, So-Young Park, Jeong Ho Lim, Hee Jin Chun, Afsha Fatima Qadri, Ye Chan Hwang, Arif Tasleem Jan, Syed Sayeed Ahmad, Shahid Ali, Sibhghatulla Shaikh, Eun Ju Lee, Inho Choi

Summary: This article provides an overview of the functions of MSTN in muscle development and its involvement in various muscle-related disorders. Different methods and strategies used to inhibit MSTN activity are reviewed.

FRONTIERS IN PHYSIOLOGY (2022)

Article Medicine, General & Internal

Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia

Seong Ho Kim, Ji Young Kim, Eun Song Kim, Il Rae Park, Eun Yeong Ha, Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee

Summary: This study found that early glycaemic variability (GV) is associated with increased 28-day mortality and prolonged ICU stay in critically ill patients with pneumonia. The presence of diabetes or HbA1c levels alone cannot predict the mortality and ICU stay in these patients. Patients with high GV, especially those with diabetes or low HbA1c levels, should be carefully treated to reduce mortality and prolong ICU stay.

ANNALS OF MEDICINE (2022)

Article Environmental Sciences

Perfluorinated compounds in adults and their association with fasting glucose and incident diabetes: a prospective cohort study

Seung Min Chung, Dong-Gyu Heo, Ju-Hyun Kim, Ji Sung Yoon, Hyoung Woo Lee, Jong-Yeon Kim, Jun Sung Moon, Kyu Chang Won

Summary: This study aimed to investigate the association between serum levels of PFOA and PFOS and diabetes. The results showed that exposure to PFOA and PFOS may have a detrimental effect on blood glucose, with particularly high risk for diabetes in individuals exposed to PFOA.

ENVIRONMENTAL HEALTH (2022)

Article Endocrinology & Metabolism

Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial

Yong-ho Lee, Doo-Man Kim, Jae Myung Yu, Kyung Mook Choi, Sin Gon Kim, Kang Seo Park, Hyun-Shik Son, Choon Hee Chung, Kyu Jeung Ahn, Soon Hee Lee, Ki-Ho Song, Su Kyoung Kwon, Hyeong Kyu Park, Kyu Chang Won, Hak Chul Jang

Summary: This study compared the effects of anagliptin 100 mg BID versus sitagliptin 100 mg QD on managing glycaemic variability and found that the anagliptin BID regimen was superior in blood glucose control after dinner, as indicated by MAGE and TIR, but was equivalent to the QD regimen in terms of HbA1c and FPG.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance

Jun Sung Moon, Nam Hoon Kim, Jin Oh Na, Jae Hyoung Cho, In-Kyung Jeong, Soon Hee Lee, Ji-Oh Mok, Nan Hee Kim, Dong Jin Chung, Jinhong Cho, Dong Woo Lee, Sun Woo Lee, Kyu Chang Won

Summary: This study evaluated the safety and effectiveness of empagliflozin in Korean patients with type 2 diabetes mellitus. It was found that empagliflozin had a good glycemic and weight-reducing effect, with no serious adverse events.

DIABETES & METABOLISM JOURNAL (2023)

Review Endocrinology & Metabolism

Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement

Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon

Summary: Diabetes mellitus is a significant risk factor for heart failure, with worse prognosis in diabetic patients. Early diagnosis and proper management of heart failure in diabetic patients are crucial. This review discusses the diagnosis criteria, screening tools, recommended pharmacological therapies, and effects of anti-diabetic medications on heart failure.

DIABETES & METABOLISM JOURNAL (2023)

Article Endocrinology & Metabolism

Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trial

Ye Seul Yang, Kyung Wan Min, Seok-O Park, Kyung-Soo Kim, Jae Myung Yu, Eun-Gyoung Hong, Sung Rae Cho, Kyu Chang Won, Yong Hyun Kim, Seungjoon Oh, Sung Hee Choi, Gwanpyo Koh, Wan Huh, Su Young Kim, Kyong Soo Park

Summary: This study aimed to evaluate and compare the efficacy and safety of enavogliflozin, a newly developed sodium-glucose cotransporter 2 inhibitor, with placebo in Korean patients with type 2 diabetes mellitus. The results showed that once-daily enavogliflozin monotherapy for 12 weeks is an effective, safe, and well-tolerated treatment for Korean patients with type 2 diabetes mellitus.

DIABETES OBESITY & METABOLISM (2023)

Article Environmental Sciences

Perfluorooctane sulfonate-induced oxidative stress contributes to pancreatic ll-cell apoptosis by inhibiting cyclic adenosine monophosphate pathway: Prevention by pentoxifylline

Suma Elumalai, Udayakumar Karunakaran, Kyu Chang Won, Seung Min Chung, Jun Sung Moon

Summary: Chronic exposure to perfluorooctane sulfonate (PFOS) stimulates insulin secretion from pancreatic β-cells through the activation of RAC1-NOX2/gp91phox and inhibition of cAMP/PKA signaling, resulting in mitochondrial dysfunction and endoplasmic stress. Inhibition of RAC1-NOX2/gp91phox activation or elevation of cAMP levels restores insulin secretory function. However, inhibition of cAMP/PKA signaling impairs pentoxifylline-induced insulin secretion. Overall, our study reveals the direct chronic effect of PFOS on β-cell failure and suggests potential therapeutic targets for PFOS-induced β-cell dysfunction.

ENVIRONMENTAL POLLUTION (2023)

暂无数据